Zurueck zur Suche

Reporte zur Charge U038854

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

12Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 10 NM 1 UT 1

VAERS 2627671

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038854

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
05.05.2023
Impfdatum
25.04.2023
Beginn
25.04.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AEs; expired dose of ROTATEQ was administered.; This spontaneous report was received from a nurse and referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions and allergies were not reported. On 25-APR-2023, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 2 milliliter, lot #U038854, expiration date: 20-APR-2023, administered orally for prophylaxis (strength was not provided) (expired product administered). No additional adverse events (AEs).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2547949

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038854

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
02.01.2023
Impfdatum
05.12.2022
Beginn
05.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional AEs; it was reported multiple temperature excursion 16-NOV-2022 and 09-DEC-2022 and were administered PEDVAXHIB, ROTATEQ and VAQTA; This spontaneous report was received from a medical assistant and refers to an unspecified group of patients of unknown age and gender. Their medical history, concurrent conditions and concomitant therapies were not reported. On 16-NOV-2022 and 09-DEC-2022, the patients were vaccinated with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot number: U029144 and expiration date: 31-MAR-2024; with Hepatitis A Vaccine, Inactivated (VAQTA) lot number: W015191 and expiration date: 27-OCT-2023; and with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot number: U038854 and expiration date: 20-APR-2023. The vaccines were administered only once for prophylaxis, but dosage regimens, route of administrations and anatomical locations were not reported. It was reported that the vaccines were administered after multiple temperature excursions (product storage error). Temperature was above 47 Fahrenheit (F) degree (50.0 F) for 0 hours 12 minutes and 0 seconds on 16-NOV-2022 and above 47 F (47.6F) for 0 hours 15 minutes and 0 seconds. Time frame was total 27 minutes. Additionally, no previous temperature excursion was reported. No other adverse event was reported (no adverse event). Follow-up information was received from the medical assistant on 28-DEC-2022. This report refers to a 11 week old patient who was vaccinated on 05-DEC-2022 with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot number: U038854 and expiration date: 20-APR-2023, orally (PO). The primary thermometer displayed out of range temperature for less than 15 minutes. The back-up thermometer did not display max. that was out of range. Log was ran and the temperatures were within range. The primary thermometer was re-calibrated. Patients' identifiers were missing in the previous report but have now been provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2547948

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038854

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
02.01.2023
Impfdatum
05.12.2022
Beginn
05.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional AEs; it was reported multiple temperature excursion 16-NOV-2022 and 09-DEC-2022 and were administered PEDVAXHIB, ROTATEQ and VAQTA; This spontaneous report was received from a medical assistant and refers to an unspecified group of patients of unknown age and gender. Their medical history, concurrent conditions and concomitant therapies were not reported. On 16-NOV-2022 and 09-DEC-2022, the patients were vaccinated with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot number: U029144 and expiration date: 31-MAR-2024; with Hepatitis A Vaccine, Inactivated (VAQTA) lot number: W015191 and expiration date: 27-OCT-2023; and with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot number: U038854 and expiration date: 20-APR-2023. The vaccines were administered only once for prophylaxis, but dosage regimens, route of administrations and anatomical locations were not reported. It was reported that the vaccines were administered after multiple temperature excursions (product storage error). Temperature was above 47 Fahrenheit (F) degree (50.0 F) for 0 hours 12 minutes and 0 seconds on 16-NOV-2022 and above 47 F (47.6F) for 0 hours 15 minutes and 0 seconds. Time frame was total 27 minutes. Additionally, no previous temperature excursion was reported. No other adverse event was reported (no adverse event). Follow-up information was received from the medical assistant on 28-DEC-2022. This report refers to a 4 month old patient who was vaccinated on 05-DEC-2022 with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot number: U038854 and expiration date: 20-APR-2023, orally (PO). The primary thermometer displayed out of range temperature for less than 15 minutes. The back-up thermometer did not display max. that was out of range. Log was ran and the temperatures were within range. The primary thermometer was re-calibrated. Patients' identifiers were missing in the previous report but have now been provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2547947

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038854

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
02.01.2023
Impfdatum
30.11.2022
Beginn
30.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional AEs; it was reported multiple temperature excursion 16-NOV-2022 and 09-DEC-2022 and were administered PEDVAXHIB, ROTATEQ and VAQTA; This spontaneous report was received from a medical assistant and refers to an unspecified group of patients of unknown age and gender. Their medical history, concurrent conditions and concomitant therapies were not reported. On 16-NOV-2022 and 09-DEC-2022, the patients were vaccinated with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot number: U029144 and expiration date: 31-MAR-2024; with Hepatitis A Vaccine, Inactivated (VAQTA) lot number: W015191 and expiration date: 27-OCT-2023; and with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot number: U038854 and expiration date: 20-APR-2023. The vaccines were administered only once for prophylaxis, but dosage regimens, route of administrations and anatomical locations were not reported. It was reported that the vaccines were administered after multiple temperature excursions (product storage error). Temperature was above 47 Fahrenheit (F) degree (50.0 F) for 0 hours 12 minutes and 0 seconds on 16-NOV-2022 and above 47 F (47.6F) for 0 hours 15 minutes and 0 seconds. Time frame was total 27 minutes. Additionally, no previous temperature excursion was reported. No other adverse event was reported (no adverse event). Follow-up information was received from the medical assistant on 28-DEC-2022. This report refers to a 6 month old patient who was vaccinated on 30-NOV-2022 with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot number: U038854 and expiration date: 20-APR-2023, orally (PO). The primary thermometer displayed out of range temperature for less than 15 minutes. The back-up thermometer did not display max. that was out of range. Log was ran and the temperatures were within range. The primary thermometer was re-calibrated. Patients' identifiers were missing in the previous report but have now been provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2547945

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038854

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
02.01.2023
Impfdatum
05.12.2022
Beginn
05.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional AEs; it was reported multiple temperature excursion 16-NOV-2022 and 09-DEC-2022 and were administered PEDVAXHIB, ROTATEQ and VAQTA; This spontaneous report was received from a medical assistant and refers to an unspecified group of patients of unknown age and gender. Their medical history, concurrent conditions and concomitant therapies were not reported. On 16-NOV-2022 and 09-DEC-2022, the patients were vaccinated with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot number: U029144 and expiration date: 31-MAR-2024; with Hepatitis A Vaccine, Inactivated (VAQTA) lot number: W015191 and expiration date: 27-OCT-2023; and with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot number: U038854 and expiration date: 20-APR-2023. The vaccines were administered only once for prophylaxis, but dosage regimens, route of administrations and anatomical locations were not reported. It was reported that the vaccines were administered after multiple temperature excursions (product storage error). Temperature was above 47 Fahrenheit (F) degree (50.0 F) for 0 hours 12 minutes and 0 seconds on 16-NOV-2022 and above 47 F (47.6F) for 0 hours 15 minutes and 0 seconds. Time frame was total 27 minutes. Additionally, no previous temperature excursion was reported. No other adverse event was reported (no adverse event). Follow-up information was received from the medical assistant on 28-DEC-2022. This report refers to a 8 week old patient who was vaccinated on 05-DEC-2022 with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot number: U038854 and expiration date: 20-APR-2023, orally (PO). The primary thermometer displayed out of range temperature for less than 15 minutes. The back-up thermometer did not display max. that was out of range. Log was ran and the temperatures were within range. The primary thermometer was re-calibrated. Patients' identifiers were missing in the previous report but have now been provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2547944

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038854

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
02.01.2023
Impfdatum
05.12.2022
Beginn
05.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional AEs; it was reported multiple temperature excursion 16-NOV-2022 and 09-DEC-2022 and were administered PEDVAXHIB, ROTATEQ and VAQTA; This spontaneous report was received from a medical assistant and refers to an unspecified group of patients of unknown age and gender. Their medical history, concurrent conditions and concomitant therapies were not reported. On 16-NOV-2022 and 09-DEC-2022, the patients were vaccinated with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot number: U029144 and expiration date: 31-MAR-2024; with Hepatitis A Vaccine, Inactivated (VAQTA) lot number: W015191 and expiration date: 27-OCT-2023; and with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot number: U038854 and expiration date: 20-APR-2023. The vaccines were administered only once for prophylaxis, but dosage regimens, route of administrations and anatomical locations were not reported. It was reported that the vaccines were administered after multiple temperature excursions (product storage error). Temperature was above 47 Fahrenheit (F) degree (50.0 F) for 0 hours 12 minutes and 0 seconds on 16-NOV-2022 and above 47 F (47.6F) for 0 hours 15 minutes and 0 seconds. Time frame was total 27 minutes. Additionally, no previous temperature excursion was reported. No other adverse event was reported (no adverse event). Follow-up information was received from the medical assistant on 28-DEC-2022. This report refers to a 6 month old patient who was vaccinated on 05-DEC-2022 with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot number: U038854 and expiration date: 20-APR-2023, orally (PO). The primary thermometer displayed out of range temperature for less than 15 minutes. The back-up thermometer did not display max. that was out of range. Log was ran and the temperatures were within range. The primary thermometer was re-calibrated. Patients' identifiers were missing in the previous report but have now been provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2547942

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038854

gering
Staat
CA
Alter
0,3
Geschlecht
U
Eingang
02.01.2023
Impfdatum
07.12.2022
Beginn
07.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional AEs; it was reported multiple temperature excursion 16-NOV-2022 and 09-DEC-2022 and were administered PEDVAXHIB, ROTATEQ and VAQTA; This spontaneous report was received from a medical assistant and refers to an unspecified group of patients of unknown age and gender. Their medical history, concurrent conditions and concomitant therapies were not reported. On 16-NOV-2022 and 09-DEC-2022, the patients were vaccinated with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot number: U029144 and expiration date: 31-MAR-2024; with Hepatitis A Vaccine, Inactivated (VAQTA) lot number: W015191 and expiration date: 27-OCT-2023; and with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot number: U038854 and expiration date: 20-APR-2023. The vaccines were administered only once for prophylaxis, but dosage regimens, route of administrations and anatomical locations were not reported. It was reported that the vaccines were administered after multiple temperature excursions (product storage error). Temperature was above 47 Fahrenheit (F) degree (50.0 F) for 0 hours 12 minutes and 0 seconds on 16-NOV-2022 and above 47 F (47.6F) for 0 hours 15 minutes and 0 seconds. Time frame was total 27 minutes. Additionally, no previous temperature excursion was reported. No other adverse event was reported (no adverse event). Follow-up information was received from the medical assistant on 28-DEC-2022. This report refers to a 4 month old patient who was vaccinated on 07-DEC-2022 with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot number: U038854 and expiration date: 20-APR-2023, orally (PO). The primary thermometer displayed out of range temperature for less than 15 minutes. The back-up thermometer did not display max. that was out of range. Log was ran and the temperatures were within range. The primary thermometer was re-calibrated. Patients' identifiers were missing in the previous report but have now been provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2535814

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038854

gering
Staat
CA
Alter
0,5
Geschlecht
U
Eingang
17.12.2022
Impfdatum
18.11.2022
Beginn
18.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE; MA reported that one Patients ( name or initials not provided when asked) received ROTATEQ ( lot number U038854 exp: 04/20/2023) exposed to 55 F for 15 min. Temperature excursion happened on Sept 7,2022 and patient received it on 11/18/2022.; This spontaneous report was received from a Medical Assistant regarding a 6-month-old patient of an unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 07-SEP-2022, an improperly stored vaccine of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) underwent a temperature excursion of 55 degrees Fahrenheit (F) for 15 minutes. On 18-NOV-2022, the patient was vaccinated with the improper stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot #U038854, expiration date: 20-APR-2023, taken orally as prophylaxis (strength was not provided) (Product storage error). No adverse events were reported. This is one of two case received from the same reported.; Sender's Comments: US-009507513-2212USA005869:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2531612

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038854

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
15.12.2022
Impfdatum
07.11.2022
Beginn
07.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported.; HCP reported ROTATEQ was administered after a temperature excursion to a patient on Nov 7, 2022.; This spontaneous report was received from a physician assistant referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/ allergies was not provided. On 07-NOV-2022, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, administered orally, lot number: U038854, expiration date: 20-APR-2023 (dose and dose number were not reported) for prophylaxis (product storage error). No additional adverse event (AE) was reported (no adverse event). The administered dose of the suspect vaccine experienced a temperature excursion of 33.9 degrees Fahrenheit for 2 hours. There was no previous reported temperature excursion. It was unknown, whether a digital data logger was involved. This is one of two cases received from the same reporter.; Sender's Comments: US-009507513-2212USA000635:2212USA000635

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2524786

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038854

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
07.12.2022
Impfdatum
21.11.2022
Beginn
21.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported.; ROTATEQ was administered after a temperature excursion to a patient on Nov 21, 2022. No further information provided. This is case two of two. Cross reference AE case: 02294619. No additional AE reported. No PQC reported. This spontaneous report has been received from a physician assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, or concomitant medications were not reported. On 21-NOV-2022, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) for prophylaxis (lot number U038854 had been verified to be a valid number; expiration date 20-APR-2023, and upon internal validation established as the same date) (dosage, vaccination scheme, frequency, route of administration, and anatomical site of injection were not reported). The administered dose of the vaccine was stored at a temperature of 33.9 degrees Fahrenheit (F), for a time frame of 2 hours, as recorded by a digital data logger. There was no previous temperature excursion reported. There was no adverse effect reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2439333

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038854

gering
Staat
NM
Alter
-
Geschlecht
U
Eingang
10.09.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

A HCP called and reported an AE where doses of improperly stored products were possibly administered to patient(s) on unknown dates.; No additional AE reported.; This spontaneous report was received from a medical assistant regarding an unknown number of patients of unspecified age and gender. Their medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with improper storage doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot #U038854, expiration date: 20-APR-2023, taken orally (dosage regimen and strength were not provided) as prophylaxis; measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) lot #T039671, expiration date: 24-NOV-2022, lot #U017524, expiration date: 03-JUN-2023, (dosage regimen, strength, anatomical location, and route of administration were not provided) as prophylaxis; hepatitis a vaccine, inactivated (VAQTA) lot #W002889, expiration date: 06-MAR-2023, lot #U024504, expiration date: 15-OCT-2022, (dosage regimen, strength, anatomical location, and route of administration were not provided) as prophylaxis (Product storage error). No additional adverse events were reported. The improperly stored vaccines of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot #T039671 and lot #U017524), and hepatitis a vaccine, inactivated (VAQTA) lot #W002889 underwent a temperature excursion of 48 degrees Fahrenheit (F) for 10 minutes without previous excursions. The improperly stored vaccines of hepatitis a vaccine, inactivated (VAQTA) lot #U024504 underwent a temperature excursion of 49 degrees Fahrenheit (F) for 10 minutes without previous excursions (This lot was stored in a second refrigerator). This is a non-valid report due to lack of patients' identifiers.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2408395

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038854

gering
Staat
UT
Alter
0,3
Geschlecht
M
Eingang
11.08.2022
Impfdatum
10.08.2022
Beginn
10.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

Patient was at Health Department to receive 2 month old vaccines along with 4 year old brother who was receiving kindergarten vaccines. Nurse inadvertently gave 4 year old brother's vaccines (MMRV and Quadracel) to patient. Error was realized and mom was notified, Patient also received Rotateq, Hep B, Prevnar 13 and Hib to stay up to date on vaccinations. Mom was notified that patient may have rash at injection site or high fever secondary to MMRV given. Nurse will follow up with mom next week. No adverse reaction noted at this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-